MELANIE FOMBANG: Open Payments
NPI 1447779590 · HUMBLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$881 in 24 payments from 9 companies in 2025. Trend: 2023 $118 · 2024 $109 · 2025 $881
Food & beverage: $881
| Company | Payments | Amount |
|---|---|---|
| BridgeBio Pharma, Inc. | 3 | $206 |
| Amgen Inc. | 4 | $179 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $150 |
| Merck Sharp & Dohme LLC | 7 | $130 |
| Novo Nordisk Inc | 1 | $113 |
| Esperion Therapeutics, Inc. | 3 | $43 |
| Chiesi USA, Inc. | 2 | $33 |
| Azurity Pharmaceuticals, Inc. | 1 | $19 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $7 |
Products named: Attruby, REPATHA, Kerendia, Wegovy, VERQUVO, NEXLETOL, CAPVAXIVE, KENGREAL.
Industry payments across TX — which companies pay providers there.
